{"id":"W4409451046","doi":"10.1016/j.ard.2025.02.009","title":"Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"GlaxoSmithKline Biologicals; Janssen Pharmaceuticals; Bristol-Myers Squibb Canada; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Pfizer; Novartis Pharmaceuticals Corporation; Schawarz Pharma; Amgen Foundation; Eli Lilly and Company; Sun Pharma; GlaxoSmithKline; Amgen; Union Chimique Belge; AbbVie","keywords":"Medicine; Intensive care medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006615728,0.0008173309,0.0006521549,0.001058522,0.0008436654,0.004650521,0.000626961,0.005459782,0.01050979],"category_scores_gemma":[0.009121257,0.0003102976,0.0009579157,0.001017175,0.001022773,0.002531362,0.002085702,0.00677669,0.003989725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001389899,"about_ca_system_score_gemma":0.004743369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002117204,"about_ca_topic_score_gemma":0.005768328,"domain_scores_codex":[0.9974626,0.0004584102,0.0002694878,0.0002049269,0.001179247,0.000425393],"domain_scores_gemma":[0.9933965,0.002105662,0.0008257601,0.0001683313,0.002094255,0.001409386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008023636,0.000169111,0.001850181,0.002003668,0.000115899,0.0003942296,0.0001868141,0.0001238153,0.004068276,0.003180184,0.7301255,0.2569799],"study_design_scores_gemma":[0.0001190362,0.0003421,0.004184075,0.0008683914,0.0001250631,0.000418181,0.0002151573,0.00006781203,0.001807255,0.001064654,0.9907583,0.00002981674],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.004548665,0.6768466,0.000823188,0.2435366,0.0499865,0.00007256289,0.001331118,0.0001103566,0.02274442],"genre_scores_gemma":[0.04889859,0.6386405,0.002918573,0.1875905,0.08304976,0.0001451507,0.002658124,0.0001287881,0.03597001],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.01050979,"threshold_uncertainty_score":0.03515875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01706149825196272,"score_gpt":0.3065417059039769,"score_spread":0.2894802076520142,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}